Sign inJoin free

Watch / Three stocks for...

Three small caps to watch

18 Apr 20247:40

Three small caps to watch

General information only. ausbiz videos are general information only, produced by Ausbiz TV Pty Ltd, a media business that doesn’t give financial advice. They don’t take into account your objectives, financial situation or needs. Consider whether it’s right for you and read the PDS and TMD before acting on anything you watch.

About this video

Luke Winchester from Merewether Capital, shares his views on several companies and their current market performance. Luke commented on XRF Scientific (XRF), indicating that it has shown consistent mid-teen revenue and profit growth over the last two years, despite inherent cyclicality in their primarily mining customer base. He defines their third quarter update as strong, keeping them on-track for their medium-longer term thesis. Luke currently holds the XRF, expressing it's fairly priced currently and an interesting small cap for investors.

Luke also talks about Austco Healthcare (AHC), a manufacturer of nurse call systems. It's stated that the first half was weak, however, their third quarter presented exceptional results with earnings that exceed those of the entire first half. With recent acquisitions and upbeat management commentary, Luke values Austco Healthcare at less than ten times earnings, highlighting its defensive nature within the healthcare space, profitability and cashflow, and history of paying dividends.

Lastly, he discusses Dropsuite (DSE) a provider of software backup services. They've shown strong growth over the past few years with key selling points, however, they flagged increased churn rates due to competition from larger companies like Microsoft (MSFT). Luke suggests to keep a keen eye on churn rates over the upcoming quarters since he doesn't own Dropsuite stock yet, but it's on the Merewether Capital's watchlist.

Below is the full unedited transcript of this interview:

0:00

Let's get a view on the smaller end of the town now, and talk about some firms that have had trading updates in the last few days. Did they deliver or did they not? We've got Luke Winchester from Merewether Capital joining us now, XRF scientific, this provider of laboratory machines. Luke, tell us about this and what it said and how it's faring.

0:23

Hey, Juliette. Um, yeah. Obviously, the completion of the third quarter, we're starting to get a bit of news flow back in. Not just the small end of the market, but but overall and, um, uh, XF I mean, uh, frequent viewers of the program may be sick of hearing me talk about XFX. It's one I've, um, sort of owned for quite a while and spoken about quite a lot, but, um, uh, the five year chart that shows you why it's been a very good performer. Um, they had their third quarter update earlier this week, and it was business as usual in a lot of ways. Um, 13% revenue growth on last year, 15% profit before tax growth. Um, that's sort of been the the modus operandi now for XFX for probably the last two years in that sort of mid-teens, um, revenue and profit growth. Um, so a bit of lumpiness around the business, as you said, it's laboratory services for, for primarily mining customers, some heavy industry and construction, but primarily mining. So there can be some lumpiness, there can be some cyclicality. Uh, but nonetheless the business when you smooth out

1:23

quarter to quarter and sort of look at the long term trajectory, it's been quite good. And the share price reflects that. Um, for me, I do have a position with Meriwether Capital. I thought this was a nice, strong third quarter update that sort of keeps that that medium longer term thesis on track. Um, and I think it's trading on about 18, 19 times earnings, um, for FY 24. So, uh, that's a pretty reasonable price. Um, you know, I do acknowledge that the inherent cyclicality of their, their customers, their mining customers, but do note they're not as exposed to the explorers, um, and the juniors, it's much more, uh, the larger players that are in production. It's not quite as cyclical as the smaller end where you do see, um, you know, some, some real cyclicality based on commodity prices and the funding environment that they're currently in. So, um, currently holding XF, I think it's a really interesting little small cap for people. Um, I always like to bring it up on the program and put it on people's radars. Um, but fantastic execution last few years, and I think that third quarter update just shows they're on

2:23

track to continue that into that medium longer term, as I said.

2:28

To some of the other stocks that we've been looking at as well. Luke. Um, Osco Healthcare, this provider of nurse call systems, a weak first half result. But what else is sort of, you know, looking good or not good for that stock?

2:43

Yeah. So look, another one I do hold. Um, and as I said in the notes, Juliette, the first half was weak. You couldn't sort of.

2:50

Um,

2:51

you know, sugarcoat that for, for this stock, um, revenue was slightly up, but assisted by an acquisition, but, uh, profitability took a bit of a hit. And the main reason why they saw a deterioration in their gross margins for for a few reasons. But, um, you know, the management sort of said they were transitory and they were expecting to see profitability improve. Now, um, of course, when you have those sorts of, of quarters or halves where it's a bit weaker, um, you always like to see that bounceback happen as quick as possible. And for Osco Healthcare, fortunately, um, the third quarter result was exceptionally strong. So, uh, the third quarter alone, um, you know, they did 14 mil revenue compared to 22 mil for the whole first half. Uh, and then uh, 2.6 mill EBITDA compared to two mil for the first half. So they've made, you know, more earnings in the third quarter than what they made in the entire first half. And, uh, the commentary was was pretty upbeat for that to continue the fourth quarter. Um, got a couple of acquisitions they've made as well. They'll bed them down and have a full run rate into FY 25. Um, I've

3:51

got these guys trading on less than ten times earnings. Um, you know, and that's just assuming a run rate of those acquisitions. You know, management's calling out the potential to drive some synergies, not just on the cost side, but on the revenue side as well. They're sort of, uh, moving down their supply chain. And as you sort of said in the intro, these guys, uh, manufacture nurse call systems and clinical software solutions, um, they've acquired, um, you know, sales and support, uh, companies in Australia that are certified Osco resellers. So getting closer to their end customers and looking to drive them into some higher margin solutions. So, you know, management's quite upbeat about what they can do with those acquisitions. Uh, for me, trying to be a bit more conservative and say, okay, let's just assume those acquisitions run right into FY 25. As I said, I think it trades on sort of less than ten times earnings, which again, it's a small cap. It can be volatile half to half, quarter to quarter. We've seen that actually over the last sort of nine months. Uh but nonetheless in that nice defensive healthcare space, profitable cash flow, um, you know, has paid a

4:50

dividend in the past, uh, I think I think sub ten times earnings looks really attractive. So another one, I think worthy of of putting on people's watch lists and taking a closer look at.

5:00

And another one. You're taking a look at Drop Suite, a provider of software backup services primarily for Microsoft 365 users. Um, is there a strong growth kind of set to continue?

5:14

I think so. I mean, these guys have had strong growth now for sort of 2 or 3 years, almost almost like clockwork style growth, uh, sort of bolting on, uh, between about 1,000,002 million RR every quarter. Um, so, so as you said, they do a backup service. Um, it's quite it's quite low CapEx for these guys. They essentially back up office 365, Microsoft Office 365. Uh, but they do it, uh, over AWS and other non-microsoft, um, sort of cloud backup. And so, uh, the, the, the selling point to their customers is that if you're going to have office 365, you know, all your data in Microsoft's cloud back it up in an Amazon cloud or a Google Cloud or a third party cloud. And that way you're you're completely safe if there's any sort of cyber security or downtime or something like that. So, you know, the selling point makes a lot of sense. I think the chart there, you can sort of see on that five term chart, there was a drop about a year ago. And the reason for that was Microsoft came out themselves and says said that they wanted to get a bit further into that, into that vertical and sort of compete a bit

6:14

more in that cloud backup space. I think that put the market on a little bit of eggshells with regards to, um, you know, could, could this, could this entire market be eaten away by some of the larger players? Um, and so for Drop sweet, I think this was another good report today, that top line continuing to go in the right direction. All metrics are really going in the right direction. The only potential orange flag was they did call out a bit of extra churn. And as I said, I think the market's sort of been on eggshells, uh, with that churn word for these guys, because Microsoft themselves have flagged that they might want to come into the space and they do compete with some larger peers as well. And so, you know, uh, the commentary today was they're seeing a little bit of that higher churn, and particularly on a on a cost focus as well. So didn't see it in this result. To be fair. Um, Rpu continue to climb, users continue to climb. Uh, RR continue to climb. But I think that was the one question mark could keep an eye out for. But as you said, Juliet, they've they've grown so strongly over the last couple of years. And this quarter continued that, um, you know, and around that sort of cash flow

7:14

breakeven as well. So no questions around the balance sheet. And there's not one that I own, Merriweather Capital, um, I've watched it for quite a while, still trying to get my head around the competition in the industry, to be fair, and Microsoft plays a big part in that. Um, so, you know, for me, again, I'm still on the sidelines. And for people who do hold, as I said, just keep an eye on that churn. I think that is the main metric you're tracking over the next few quarters, just to show that drops week can sort of, um, hold that competitive position they've currently got.

More like this

We value your privacy

We use essential cookies to make the site work. Non-essential cookies help us improve the experience. You can accept or reject non-essential cookies. Privacy policy